See more : Hwang Chang General Contractor Co., Ltd (2543.TW) Income Statement Analysis – Financial Results
Complete financial analysis of PhytoHealth Corporation (4108.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PhytoHealth Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Tourism Holdings Limited (THL.NZ) Income Statement Analysis – Financial Results
- Formosa Electronic Industries Inc. (8171.TWO) Income Statement Analysis – Financial Results
- Frontken Corporation Berhad (0128.KL) Income Statement Analysis – Financial Results
- SK Growth Opportunities Corporation (SKGR) Income Statement Analysis – Financial Results
- Selic Corp Public Company Limited (SELIC.BK) Income Statement Analysis – Financial Results
PhytoHealth Corporation (4108.TW)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.phytohealth.com.tw
About PhytoHealth Corporation
PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 162.49M | 135.47M | 168.94M | 91.81M | 95.49M | 107.48M | 54.00M | 25.02M | 20.98M | 90.73M | 144.99M | 177.71M | 155.09M | 107.90M | 99.19M |
| Cost of Revenue | 94.85M | 78.43M | 90.62M | 46.31M | 31.91M | 52.42M | 29.78M | 12.53M | 18.27M | 88.89M | 146.38M | 161.91M | 144.42M | 98.61M | 87.40M |
| Gross Profit | 67.64M | 57.03M | 78.31M | 45.50M | 63.58M | 55.07M | 24.21M | 12.49M | 2.70M | 1.84M | -1.39M | 15.80M | 10.67M | 9.29M | 11.80M |
| Gross Profit Ratio | 41.63% | 42.10% | 46.36% | 49.56% | 66.59% | 51.23% | 44.84% | 49.92% | 12.89% | 2.03% | -0.96% | 8.89% | 6.88% | 8.61% | 11.89% |
| Research & Development | 92.59M | 119.52M | 120.47M | 124.72M | 164.07M | 168.00M | 146.14M | 161.61M | 175.27M | 263.38M | 176.53M | 89.94M | 163.51M | 171.56M | 208.63M |
| General & Administrative | 61.06M | 61.35M | 62.76M | 61.68M | 81.49M | 92.92M | 85.23M | 83.13M | 93.89M | 84.16M | 62.44M | 63.60M | 25.55M | 37.69M | 30.56M |
| Selling & Marketing | 35.67M | 32.88M | 27.29M | 29.44M | 23.27M | 24.28M | 14.20M | 6.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 96.73M | 94.23M | 90.06M | 91.12M | 104.77M | 117.21M | 99.43M | 90.11M | 93.89M | 84.16M | 62.44M | 63.60M | 25.55M | 37.69M | 30.56M |
| Other Expenses | 0.00 | 30.09M | 28.17M | 48.66M | 30.59M | 35.56M | 2.27M | 2.97M | 29.28M | -1.56M | 48.12M | 7.13M | 12.64M | 17.42M | 10.81M |
| Operating Expenses | 67.64M | 213.75M | 210.52M | 215.84M | 299.43M | 323.90M | 292.57M | 251.72M | 269.15M | 347.54M | 238.96M | 153.54M | 204.11M | 227.97M | 255.38M |
| Cost & Expenses | 284.17M | 292.18M | 301.14M | 262.15M | 331.33M | 376.32M | 322.35M | 264.25M | 287.43M | 436.43M | 385.34M | 315.45M | 348.53M | 326.58M | 342.78M |
| Interest Income | 18.40M | 12.16M | 8.83M | 5.76M | 7.48M | 8.68M | 11.28M | 12.28M | 12.22M | 0.00 | 0.00 | 3.35M | 2.05M | 830.00K | 474.00K |
| Interest Expense | 344.00K | 312.00K | 405.00K | 240.00K | 268.00K | 158.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 170.00K | 0.00 | 0.00 | 141.00K |
| Depreciation & Amortization | 53.11M | 52.44M | 52.81M | 54.89M | 65.08M | 54.74M | 50.19M | 48.91M | 48.51M | 53.34M | 48.27M | 20.88M | 16.18M | 21.36M | 23.13M |
| EBITDA | -20.70M | -61.97M | -42.30M | -61.13M | -139.42M | -153.88M | -193.73M | -190.58M | -218.51M | -293.92M | -143.97M | -90.93M | -172.33M | -197.32M | -245.61M |
| EBITDA Ratio | -12.74% | -45.78% | -25.10% | -66.47% | -146.11% | -143.16% | -404.14% | -760.87% | -899.32% | -323.94% | -99.30% | -58.06% | -104.39% | -163.16% | -204.48% |
| Operating Income | -121.68M | -114.46M | -95.21M | -115.92M | -204.59M | -268.83M | -268.35M | -239.23M | -266.45M | -345.70M | -240.36M | -137.74M | -193.44M | -218.68M | -243.58M |
| Operating Income Ratio | -74.88% | -84.49% | -56.36% | -126.26% | -214.27% | -250.12% | -496.99% | -956.12% | -1,270.14% | -381.01% | -165.78% | -77.51% | -124.73% | -202.66% | -245.56% |
| Total Other Income/Expenses | 47.53M | 41.94M | 36.59M | 54.18M | 491.00K | 21.44M | 24.44M | 25.32M | 29.28M | -1.56M | 48.12M | 25.76M | 4.93M | -6.05M | -25.02M |
| Income Before Tax | -74.15M | -114.72M | -95.52M | -116.26M | -204.77M | -208.77M | -243.92M | -213.91M | -237.17M | -347.26M | -192.24M | -111.98M | -188.51M | -224.72M | -268.60M |
| Income Before Tax Ratio | -45.63% | -84.69% | -56.54% | -126.63% | -214.45% | -194.24% | -451.73% | -854.93% | -1,130.58% | -382.73% | -132.59% | -63.01% | -121.55% | -208.26% | -270.79% |
| Income Tax Expense | 0.00 | 312.00K | -17.50M | 2.40M | -33.84M | 60.22M | -37.62M | 15.18M | 4.99M | 24.00K | 24.00K | 11.00K | -5.36M | 22.00K | 91.00K |
| Net Income | -47.12M | -115.04M | -78.02M | -118.66M | -170.93M | -182.48M | -206.35M | -194.52M | -203.50M | -321.70M | -182.96M | -103.79M | -170.07M | -215.12M | -267.05M |
| Net Income Ratio | -29.00% | -84.92% | -46.18% | -129.24% | -179.01% | -169.77% | -382.16% | -777.41% | -970.06% | -354.56% | -126.19% | -58.41% | -109.66% | -199.36% | -269.23% |
| EPS | -0.24 | -0.58 | -0.40 | -0.70 | -1.01 | -1.08 | -1.22 | -1.15 | -1.21 | -1.97 | -1.12 | -0.74 | -1.24 | -1.52 | -2.30 |
| EPS Diluted | -0.24 | -0.58 | -0.40 | -0.70 | -1.01 | -1.08 | -1.22 | -1.15 | -1.21 | -1.91 | -1.09 | -0.74 | -1.24 | -1.51 | -2.28 |
| Weighted Avg Shares Out | 198.62M | 198.62M | 195.70M | 168.70M | 168.70M | 168.70M | 168.70M | 168.70M | 168.70M | 163.62M | 163.54M | 140.75M | 136.80M | 141.38M | 115.92M |
| Weighted Avg Shares Out (Dil) | 198.62M | 198.62M | 195.70M | 168.70M | 168.70M | 168.70M | 168.70M | 168.70M | 168.70M | 168.70M | 168.63M | 140.93M | 137.15M | 142.34M | 117.19M |
Source: https://incomestatements.info
Category: Stock Reports